1. Home
  2. IOBT vs GIFT Comparison

IOBT vs GIFT Comparison

Compare IOBT & GIFT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • IOBT
  • GIFT
  • Stock Information
  • Founded
  • IOBT 2014
  • GIFT 1999
  • Country
  • IOBT Denmark
  • GIFT United States
  • Employees
  • IOBT N/A
  • GIFT N/A
  • Industry
  • IOBT Biotechnology: Pharmaceutical Preparations
  • GIFT Catalog/Specialty Distribution
  • Sector
  • IOBT Health Care
  • GIFT Consumer Discretionary
  • Exchange
  • IOBT Nasdaq
  • GIFT Nasdaq
  • Market Cap
  • IOBT 57.9M
  • GIFT N/A
  • IPO Year
  • IOBT 2021
  • GIFT N/A
  • Fundamental
  • Price
  • IOBT $1.16
  • GIFT $2.17
  • Analyst Decision
  • IOBT Strong Buy
  • GIFT Strong Buy
  • Analyst Count
  • IOBT 3
  • GIFT 1
  • Target Price
  • IOBT $9.33
  • GIFT $4.00
  • AVG Volume (30 Days)
  • IOBT 213.3K
  • GIFT 138.4K
  • Earning Date
  • IOBT 05-13-2025
  • GIFT 05-15-2025
  • Dividend Yield
  • IOBT N/A
  • GIFT N/A
  • EPS Growth
  • IOBT N/A
  • GIFT N/A
  • EPS
  • IOBT N/A
  • GIFT N/A
  • Revenue
  • IOBT N/A
  • GIFT $86,439,146.00
  • Revenue This Year
  • IOBT $59.29
  • GIFT $3.23
  • Revenue Next Year
  • IOBT N/A
  • GIFT $25.39
  • P/E Ratio
  • IOBT N/A
  • GIFT N/A
  • Revenue Growth
  • IOBT N/A
  • GIFT N/A
  • 52 Week Low
  • IOBT $0.66
  • GIFT $0.50
  • 52 Week High
  • IOBT $1.79
  • GIFT $4.27
  • Technical
  • Relative Strength Index (RSI)
  • IOBT 67.95
  • GIFT N/A
  • Support Level
  • IOBT $0.90
  • GIFT N/A
  • Resistance Level
  • IOBT $1.37
  • GIFT N/A
  • Average True Range (ATR)
  • IOBT 0.10
  • GIFT 0.00
  • MACD
  • IOBT 0.03
  • GIFT 0.00
  • Stochastic Oscillator
  • IOBT 60.97
  • GIFT 0.00

About IOBT IO Biotech Inc.

IO Biotech Inc is a clinical-stage biopharmaceutical company developing novel, immune-modulating cancer vaccines based on T-win technology platform. The product candidates are designed to induce the immune system to simultaneously target and disrupt multiple pathways that regulate tumor-induced immunosuppression.

Share on Social Networks: